Alphyn Biologics
Annapolis, MD
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.
alphynbiologics.comCompany Details
Founded
- 2019
Employees
- Between 2 - 10 employees
Raised
- $11,828,198
Headquarters Location
- Annapolis, MD
Public
- No
Acquired
- No
CEO
Neal Koller
Founders
- Neal Koller
Company Collections
These are collections Alphyn Biologics is a part of. Click on the collection name to view similar companies.
Alphyn Biologics' Industries
Alphyn Biologics Headquarters Location
3724a Thomas Point Road, Annapolis, MD 21403
Total Amount Raised: $11,828,198
Alphyn Biologics Funding Rounds
Series Unknown
$5,172,484
Series Unknown
$1,185,717
Series A
$3,300,000
Series A Investors
Queen City AngelsAngel Physicians FundSerial Stage Venture PartnersSeries Unknown
$2,169,997
Funding info provided by Diffbot.
Alphyn Biologics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Alphyn Biologics.